Amedeo Smart

Free Medical Literature Service

 

Amedeo

Contraception and Contraceptive Drugs
  Free Subscription

Articles published in
BMJ
    July 2026
  1. LANGE IH, Hemmingsen CH, Meaidi A, Hannaford PC, et al
    Contemporary hormonal contraception and colorectal cancer in premenopausal women: nationwide cohort study.
    BMJ. 2026;394:e100065.
    >> Share

  2. BATUR P
    Hormonal contraception and colorectal cancer.
    BMJ. 2026;394:e100222.
    >> Share

    September 2025
  3. TAYLOR L
    Almost $10m of "incinerated" US aid contraceptives found safe, but still at risk.
    BMJ. 2025;390:r1951.
    >> Share

    August 2025
  4. BOWIE K
    France pressured to stop US plan to destroy almost $10m of aid funded contraceptives.
    BMJ. 2025;390:r1631.
    >> Share

    July 2025
  5. SCHUMMERS L, Cheng L, Odendaal M, Rodriguez-Llorian E, et al
    Effect of universal no-cost coverage on use of long-acting reversible contraception and all prescription contraception: population based, controlled, interrupted time series analysis.
    BMJ. 2025;390:e083874.
    >> Share

    June 2025
  6. ROLAND N, Kolla E, Baricault B, Dayani P, et al
    Oral contraceptives with progestogens desogestrel or levonorgestrel and risk of intracranial meningioma: national case-control study.
    BMJ. 2025;389:e083981.
    >> Share

  7. O'DOWD A
    Weight loss drugs could make oral contraception less effective, MHRA warns.
    BMJ. 2025;389:r1169.
    >> Share

    April 2025
  8. TAYLOR L
    US contraceptive guidance team is fired in new Trump cuts.
    BMJ. 2025;389:r795.
    >> Share

    February 2025
  9. MEAIDI A, Yonis H
    Research on hormonal contraceptives is needed to monitor their evolving safety profile.
    BMJ. 2025;388:r341.
    >> Share

  10. YONIS H, Lokkegaard E, Kragholm K, Granger CB, et al
    Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study.
    BMJ. 2025;388:e082801.
    >> Share

  11. JOHANSSON T
    Arterial thrombosis in users of contemporary hormonal contraception.
    BMJ. 2025;388:r237.
    >> Share

    September 2024
  12. WISE J
    Valproate: Men are advised to use contraception owing to risk of neurodevelopmental disorders in children.
    BMJ. 2024;386:q1957.
    >> Share

    August 2024
  13. ZENG X, Cheng L, Wu S, Qian X, et al
    Optimising contraceptive services as fertility rates fall in China.
    BMJ. 2024;386:e078642.
    >> Share

  14. IACOBUCCI G
    Medical abortion: Taking first tablet at home after 12 weeks of pregnancy is safe, study reports.
    BMJ. 2024;386:q1902.
    >> Share

  15. MAHASE E
    Uterine fibroids: NICE recommends new treatment option for moderate to severe symptoms.
    BMJ. 2024;386:q1805.
    >> Share

    June 2024
  16. TANNE JH
    Mifepristone: US Supreme Court rejects ban on abortion drug.
    BMJ. 2024;385:q1321.
    >> Share

  17. TANNE JH
    US Republicans block bill that would have guaranteed access to contraception.
    BMJ. 2024;385:q1251.
    >> Share

    May 2024
  18. TANNE JH
    US state classifies mifepristone and misoprostol as dangerous controlled substances.
    BMJ. 2024;385:q1175.
    >> Share

  19. COOPER KG, Bhattacharya S, Daniels JP, Horne AW, et al
    Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial.
    BMJ. 2024;385:e079006.
    >> Share

    March 2024
  20. TANNE JH
    US Supreme Court questions legitimacy of case seeking to ban mifepristone.
    BMJ. 2024;384:q763.
    >> Share

  21. ROLAND N, Neumann A, Hoisnard L, Duranteau L, et al
    Use of progestogens and the risk of intracranial meningioma: national case-control study.
    BMJ. 2024;384:e078078.
    >> Share

    February 2024
  22. MCNEE R
    Tackling contraceptive misinformation on social media.
    BMJ. 2024;384:q472.
    >> Share

  23. LOOI MK
    The grey area of "fertility tech" being mis-sold as contraception.
    BMJ. 2024;384:q54.
    >> Share

    December 2023
  24. WAGNER B, Cleland K
    Retail demand for emergency contraception in United States following New Year holiday: time series study.
    BMJ. 2023;383:e077437.
    >> Share

    November 2023
  25. LIMB M
    Pharmacy health checks and contraceptive service could save 10 million GP appointments.
    BMJ. 2023;383:p2722.
    >> Share

    September 2023
  26. MEAIDI A
    Filling in the gaps in our understanding of hormonal contraception.
    BMJ. 2023;382:2043.
    >> Share

  27. SCHMIDT M
    NSAIDs, hormonal contraception, and venous thromboembolism.
    BMJ. 2023;382:p1990.
    >> Share

  28. MEAIDI A, Mascolo A, Sessa M, Toft-Petersen AP, et al
    Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study.
    BMJ. 2023;382:e074450.
    >> Share

    August 2023
  29. TANNE JH
    US federal court upholds limits on abortion drug mifepristone.
    BMJ. 2023;382:1924.
    >> Share

  30. TANNE JH
    Combining anti-inflammatory drug with the morning after pill boosts effectiveness, study finds.
    BMJ. 2023;382:1920.
    >> Share

    July 2023
  31. TANNE JH
    FDA approves daily over-the-counter oral contraceptive with no age restrictions.
    BMJ. 2023;382:p1631.
    >> Share

    April 2023
  32. TANNE JH
    US Supreme Court allows mifepristone to remain available for now.
    BMJ. 2023;381:p923.
    >> Share

  33. MCNALLY S
    Scarlett McNally: Let's talk about contraception.
    BMJ. 2023;381:p862.
    >> Share

  34. TANNE JH
    Mifepristone remains available in US until midnight on 19 April.
    BMJ. 2023;381:864.
    >> Share

  35. TANNE JH
    Opposing rulings on mifepristone in US leave access to medical abortion in jeopardy.
    BMJ. 2023;381:822.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016